EUVIMEDEUVIMED entdecken
Crossref

Effects and mechanism of conditional osteoblast PHB1 knockout on bone metabolism in mice

Jia-Hui Li, Zheng Shan, Wen-Wei Xie, Yan-Ling Deng, Bing-Qing Wang, Shi-Long Fan, Qing-Yu Feng, Zhi-Kun Zhou

Biomedical Engineering Communications · 2026 · 5 (5) · 31

DOI: 10.53388/bmec2026031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Engineering Communications, 2026. Verfasst von Jia-Hui Li und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postmenopausal osteoporosis (PMOP) is a highly prevalent metabolic bone disorder with limited effective clinical therapies. To verify prohibitin 1 (PHB1) as a potential therapeutic target for PMOP, we generated an osteoblast-specific PHB1 conditional knockout (CKO) mouse model. This strategy is based on our preliminary results that Huangqi Sanxian Decoction enhances osteogenesis by inhibiting PHB1 expression, indicating that PHB1 may serve as a critical negative regulator of bone formation.

Methods

An osteoblast-specific PHB1 conditional knockout (CKO) mouse model was established for in vivo experiments. In vitro assays were conducted to evaluate the biological functions of PHB1 knockout on osteoblasts, including assessments of cell proliferation, differentiation, and survival. Molecular analyses were performed to detect the expression of osteogenic markers and the activity of the PI3K/Akt signaling pathway.

Results

Compared to controls, CKO mice exhibited significantly increased bone mineral density (BMD), elevated bone formation marker (PINP), and reduced bone resorption marker (CTX-1) and osteoclast number. In vitro, PHB1 knockout enhanced osteoblast proliferation, differentiation (increased ALP activity and mineralization), and survival (elevated Bcl-2/Bax ratio, decreased caspase-3), while upregulating osteogenic markers (OPN, Runx2). Mechanistically, the PI3K/Akt pathway was activated, as indicated by an increased p-Akt/Akt ratio.

Conclusion

These findings demonstrate that osteoblast-specific PHB1 deletion promotes bone formation and inhibits resorption via the PI3K/Akt pathway, offering a mechanistic foundation for PHB1-targeted therapies in PMOP.

Zitieren

APA

Li, J., Shan, Z., Xie, W., Deng, Y., Wang, B., Fan, S., Feng, Q., & Zhou, Z. (2026). Effects and mechanism of conditional osteoblast PHB1 knockout on bone metabolism in mice. Biomedical Engineering Communications, 5(5), 31. https://doi.org/10.53388/bmec2026031

Vancouver

Li J, Shan Z, Xie W, Deng Y, Wang B, Fan S, et al. Effects and mechanism of conditional osteoblast PHB1 knockout on bone metabolism in mice. Biomedical Engineering Communications. 2026;5(5):31. doi:10.53388/bmec2026031

BibTeX
@article{Li2026,
  author = {Li, Jia-Hui and Shan, Zheng and Xie, Wen-Wei and Deng, Yan-Ling and Wang, Bing-Qing and Fan, Shi-Long and Feng, Qing-Yu and Zhou, Zhi-Kun},
  title = {Effects and mechanism of conditional osteoblast PHB1 knockout on bone metabolism in mice},
  journal = {Biomedical Engineering Communications},
  year = {2026},
  volume = {5},
  number = {5},
  pages = {31},
  doi = {10.53388/bmec2026031}
}
Kostenlos starten →